Opinion
Industry legend Jim Devine is irreplaceable
David Pinto writes that Jim Devine spent a lifetime in chain drug retailing, and anyone or anything he touched was better for the experience.
The implications of Sycamore Partners’ blockbuster acquisition of WBA
The acquisition aims to reinforce Walgreens, Boots and other consumer brands by leveraging WBA’s health care expertise and Sycamore’s strength in retail.
Some conspicuous absences from Fortune’s list
David Pinto writes that surprising to some and not so surprising to others was the absence of any drug chain from the list.
Jim Tsipakis makes Giant Eagle a holistic space
“Our pharmacy business has never been stronger. We continue to grow and fill the needs of our guests,” Tsipakis says.
2025 Health Care Outlook: Micah Cost, PQA
By Micah Cost, CEO, Pharmacy Quality Alliance (PQA)
2025 Health Care Outlook: Sandra Hanna, Neighbourhood Pharmacies
By Sandra Hanna, CEO Neighbourhood Pharmacies.
An Action Plan! For the future of shoppers’ health
Global and personal challenges reshape health priorities, writes Candace Corlett, President of WSL Strategic Retail.
Prospects for PBM reform in 2025 look good
As the new year gets under way, the pharmacy sector has a legitimate shot at making meaningful progress toward realizing that ambitious goal of PBM reform.
Convenience is the new retail king in Great Britain
David Pinto looks at the newest, or not so new, emerging retail format in the United Kingdom: the corner store.
CHPA’s Melville: O-T-Cs are essential self-care avenue
By Scott Melville, President, and CEO of the Consumer Healthcare Products Association
2025 Health Care Outlook: Sheila Arquette, NASP
By Sheila Arquette, President and CEO, National Association of Specialty Pharmacy (NASP)
2025 Health Care Outlook: John O'Brien, NPC
By John O’Brien, president and CEO of the National Pharmaceutical Council.
2025 Health Care Outlook: Susan Cantrell, AMCP
By Susan Cantrell, Susan Cantrell CEO, Academy of Managed Care Pharmacy.
2025 Health Care Outlook: Peter Matz, FMI
By Peter Matz, Director of Food, Pharmacy and Health Policy at FMI – The Food Industry Association
